Anshi Pharmaceutical Research (Zhongshan) Co., Ltd. (hereinafter referred to as the Institute) is a company of the Anshi Group with a registered capital of 20 million RMB. It is committed to the research and development of Chinese and American APIs & preparations. Research fields include research and development of pharmaceuticals, health products, food, and cosmetics, as well as technology development, technology transfer, and technical services for chemical raw materials, pharmaceutical intermediates, bioengineered products, and biomedical products.
The Institute consists of three companies’R&D teams: Anshi Pharmaceutical (Zhongshan) Co., Ltd., Bailing Biotechnology Co., Ltd. and Hefei Tianyuan Medicine Research Institute.
The Institute covers an area of 2,200 square meters and divided into Administrative areas and Experimental areas.